Related Experiment Video
Updated: Jul 17, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Aortic valve calcification in systemic lupus erythematosus
A N Kiani1, E K Fishman, M Petri
1Division of Rheumatology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.
Insights
Aortic valve calcification is rare in systemic lupus erythematosus (SLE) but linked to novel cardiovascular risks and hypercoagulability. Unlike the general population, it
Area of Science:
- Cardiology
- Rheumatology
- Vascular Biology
Background:
- Aortic valve calcification (AVC) commonly associates with atherosclerosis in the general population.
- Systemic lupus erythematosus (SLE) is an autoimmune disease with increased cardiovascular risk.
- The prevalence and associations of AVC in SLE patients are not well-established.
Purpose of the Study:
- To investigate the prevalence of AVC in patients with SLE.
- To identify factors associated with AVC in this cohort.
Main Methods:
- Helical CT scans were used to assess AVC in 199 SLE patients.
- Patient demographics, cardiovascular risk factors, medications, and antiphospholipid antibody status were analyzed.
- Statistical analysis identified significant associations with AVC.
Main Results:
- AVC was present in 1.5% of SLE patients, contrasting with 43% coronary calcium and 17% carotid plaque.
- Associations were found with high-sensitivity C-reactive protein (hs-CRP), fibrinogen, lipoprotein(a), prednisone, methotrexate, and antiphospholipid antibody positivity (lupus anticoagulant).
- AVC was not associated with coronary calcium or carotid plaque in SLE patients.
Conclusions:
- AVC is uncommon in SLE patients but linked to specific cardiovascular risk factors and hypercoagulability.
- Unlike the general population, AVC in SLE does not correlate with subclinical atherosclerosis markers like coronary calcium or carotid plaque.
- These findings suggest unique pathophysiological mechanisms for AVC in SLE.
Abstract:
Aortic valve calcification is associated with atherosclerosis in the general population. We investigated the prevalence of and associates of aortic valve calcification in systemic lupus erythematosus (SLE). One-hundred and ninety-nine SLE patients enrolled in a clinical trial had aortic valve calcification assessed by helical CT. The patients had a mean age of 44.3 +/- 11.4 years and were 92% female, 61% Caucasian, 34% African-American, 2% Asian and 2% Hispanic. Aortic valve calcification was present in 1.5%, whereas coronary calcium was found in 43% and carotid plaque in 17%. Among cardiovascular risk factors, hs-CRP (P = 0.0592), fibrinogen (P = 0.0507), and lipoprotein(a) (P = 0.0250), were associated with aortic valve calcification. Prednisone use (P = 0.049) and use of methotrexate (P = 0.0174) were also associated with aortic valve calcification. Aortic valve calcification was associated with antiphospholipid antibody positivity (0.0287) (lupus anticoagulant, by dilute Russell viper venom time). It was not associated with coronary calcium or carotid plaque. Aortic valve calcification, although rare in SLE, was associated with some novel cardiovascular risk factors and with a marker of hypercoagulability (lupus anticoagulant). In contrast to the general population, aortic valve calcification in SLE is not associated with subclinical measures of atherosclerosis, such as coronary calcium or carotid plaque.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction

